Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guarini

Showing results (451-460 of 826) with videos related to

Pageof 83
Sort By:
Hellenic Journal of Nuclear Medicine|January 7, 2014
Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphomaCristina Ferrari, Carla Minoia, Artor Niccoli Asabella, et al.
Computer Methods and Programs in Biomedicine|December 13, 2023
SurvIAE: Survival prediction with Interpretable Autoencoders from Diffuse Large B-Cells Lymphoma gene expression dataGian Maria Zaccaria, Nicola Altini, Giuseppe Mezzolla, et al.
Nanomaterials (Basel, Switzerland)|May 6, 2020
The Terahertz Dynamics of an Aqueous Nanoparticle Suspension: An Inelastic X-ray Scattering StudyAlessio De De Francesco, Luisa Scaccia, Ferdinando Formisano, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 18, 2002
MC(3) receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmiasSalvatore Guarini, Helgi B Schiöth, Chiara Mioni, et al.
Hellenic Journal of Nuclear Medicine|December 11, 2020
Is whole body low dose CT still necessary in the era of <sup>18</sup>F-FDG PET/CT for the assessment of bone disease in multiple myeloma patients?Nicola Maggialetti, Cristina Ferrari, Anna Giulia Nappi, et al.
International Journal of Cancer|December 15, 1990
Expression and modulation by cytokines of the intercellular adhesion molecule-1 (ICAM-1) in human central nervous system tumor cell culturesL Guarini, M Temponi, J N Bruce, et al.
Atherosclerosis|January 8, 2008
Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertensionSimonetta Friso, Francesca Pizzolo, Sang-Woon Choi, et al.
Molecular Neurobiology|August 10, 2017
Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In VivoFrancesca Vaglini, Carla Pardini, Teresa Di Desidero, et al.
Leukemia|January 1, 1992
Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findingsR Foa, G Meloni, A Guarini, et al.
British Journal of Haematology|May 1, 1990
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid originR Foa, P Caretto, M T Fierro, et al.
Pageof 83

Showing results (451-460 of 826) with videos related to

Sort By:
Pageof 83
Hellenic Journal of Nuclear Medicine|January 7, 2014
Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphomaCristina Ferrari, Carla Minoia, Artor Niccoli Asabella, et al.
Computer Methods and Programs in Biomedicine|December 13, 2023
SurvIAE: Survival prediction with Interpretable Autoencoders from Diffuse Large B-Cells Lymphoma gene expression dataGian Maria Zaccaria, Nicola Altini, Giuseppe Mezzolla, et al.
Nanomaterials (Basel, Switzerland)|May 6, 2020
The Terahertz Dynamics of an Aqueous Nanoparticle Suspension: An Inelastic X-ray Scattering StudyAlessio De De Francesco, Luisa Scaccia, Ferdinando Formisano, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 18, 2002
MC(3) receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmiasSalvatore Guarini, Helgi B Schiöth, Chiara Mioni, et al.
Hellenic Journal of Nuclear Medicine|December 11, 2020
Is whole body low dose CT still necessary in the era of <sup>18</sup>F-FDG PET/CT for the assessment of bone disease in multiple myeloma patients?Nicola Maggialetti, Cristina Ferrari, Anna Giulia Nappi, et al.
International Journal of Cancer|December 15, 1990
Expression and modulation by cytokines of the intercellular adhesion molecule-1 (ICAM-1) in human central nervous system tumor cell culturesL Guarini, M Temponi, J N Bruce, et al.
Atherosclerosis|January 8, 2008
Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertensionSimonetta Friso, Francesca Pizzolo, Sang-Woon Choi, et al.
Molecular Neurobiology|August 10, 2017
Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In VivoFrancesca Vaglini, Carla Pardini, Teresa Di Desidero, et al.
Leukemia|January 1, 1992
Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findingsR Foa, G Meloni, A Guarini, et al.
British Journal of Haematology|May 1, 1990
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid originR Foa, P Caretto, M T Fierro, et al.
Pageof 83